Skip to Content

Certain Prostate Drugs Tied to Risk for Parkinson Disease

THURSDAY, Feb. 18, 2021 -- Users of terazosin, doxazosin, or alfuzosin are at lower risk for developing Parkinson disease (PD) compared with users of tamsulosin, according to a study published online Feb. 1 in JAMA Neurology.

Jacob E. Simmering, Ph.D., from the University of Iowa in Iowa City, and colleagues assessed whether use of terazosin, doxazosin, and alfuzosin is associated with a decreased risk for developing PD versus use of tamsulosin. The analysis included 52,365 propensity score-matched pairs of terazosin/doxazosin/alfuzosin users and tamsulosin users identified in Danish registries and 94,883 propensity score-matched pairs identified in the U.S. Truven database.

Patients in the Danish cohort who used terazosin/doxazosin/alfuzosin had a lower risk for developing PD (hazard ratio [HR], 0.88; 95 percent confidence interval [CI], 0.81 to 0.98), as did patients in the Truven cohort (HR, 0.63; 95 percent CI, 0.58 to 0.69). A dose-response association was detected, with greater risk reduction tied to longer use of terazosin/doxazosin/alfuzosin in the Danish cohort (short-term use: HR, 0.95; 95 percent CI, 0.84 to 1.07; medium-term use: HR, 0.88; 95 percent CI, 0.77 to 1.01; long-term use: HR, 0.79; 95 percent CI, 0.66 to 0.95) and in the Truven cohort (short-term use: HR, 0.70; 95 percent CI, 0.64 to 0.76; medium-term use: HR, 0.58; 95 percent CI, 0.52 to 0.64; long-term use: HR, 0.46; 95 percent CI, 0.36 to 0.57).

"Despite the relative differences in population and health care system structure, we found a similar protective effect in both countries," Simmering said in a statement. "The replication of the finding in an international cohort is powerful evidence suggesting a causal effect."

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Telehealth Use Up Markedly Among Parkinson Patients

WEDNESDAY, Feb. 10, 2021 -- Parkinson disease (PD) symptoms and management practices were markedly affected by COVID-19, according to a study published online Jan. 21 in npj...

Smartwatch Sensors Could Monitor Parkinson Disease Symptoms

FRIDAY, Feb. 5, 2021 -- The Motor Fluctuations Monitor for Parkinson's Disease (MM4PD) ambulatory monitoring system can facilitate continuous symptom monitoring through a...

Schizophrenia Tied to Increased Risk for Later Parkinson Disease

MONDAY, Feb. 1, 2021 -- Schizophrenia spectrum disorder increases the risk for Parkinson disease (PD) later in life, according to a study published online Jan. 6 in Movement...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.